Efficacy of Topical Treatment of Low-Risk Cervical Preinvasive Lesions with Glycyrrhizinic Acid

Simple item page
dc.contributor.authorAndžāne, Diāna
dc.contributor.authorŽodžika, Jana
dc.contributor.authorJermakova, Irina
dc.contributor.authorSenfelde, Ilva
dc.contributor.authorUtorova, Marina
dc.contributor.authorRezeberga, Dace
dc.contributor.institutionDepartment of Clinical Skills and Medical Technologies
dc.contributor.institutionDepartment of Obstetrics and Gynaecology
dc.date.accessioned2025-01-29T13:55:01Z
dc.date.available2025-01-29T13:55:01Z
dc.date.issued2025-01
dc.descriptionPublisher Copyright: © 2024 by the authors.
dc.description.abstractBackground/Objectives: The study aimed to investigate the efficacy of medication treatment with glycyrrhizinic acid for cervical intraepithelial neoplasia (CIN) 1 lesions. Methods: Women with histologically confirmed CIN 1 in cervical biopsies were included in the prospective study. Participants of the study group used glycyrrhizinic acid spray (Epigen spray) topically 10 days (Epigen 10-day subgroup) or 20 days (Epigen 20-day subgroup) per month for 6 months. Women in the control group had no treatment. There were two follow-up visits 6 months apart. All patients were screened for human papillomavirus (HPV) before enrollment and during the first follow-up visit. Results: There were 50 patients in the Epigen group and 50 patients in the control group. At the first follow-up visit, in the histological findings, progression to CIN 2+ was 6.7% in the Epigen 20-day subgroup, 31.1% in the control group, and the persistence of CIN 1 was 86.7% in the Epigen 20-day subgroup and 62.2% in the control group, p = 0.03. Large loop excision of the transformation zone (LLETZ) was statistically significantly more frequent in the control group after the first follow-up visit (10% in the Epigen 20-day subgroup vs. 30% in the control group, p = 0.032). No such relationships were found during the second follow-up visit. Conclusions: The vaginal spray of the glycyrrhizinic acid used 20 days per month appears to decrease the risk of the progression of CIN 1 lesions, with the need to perform LLETZ. However, a similar effect is not observed after stopping usage.en
dc.description.statusPeer reviewed
dc.format.extent2297810
dc.identifier.citationAndžāne, D, Žodžika, J, Jermakova, I, Senfelde, I, Utorova, M & Rezeberga, D 2025, 'Efficacy of Topical Treatment of Low-Risk Cervical Preinvasive Lesions with Glycyrrhizinic Acid', Journal of Clinical Medicine, vol. 14, no. 1, 136. https://doi.org/10.3390/jcm14010136
dc.identifier.doi10.3390/jcm14010136
dc.identifier.issn2077-0383
dc.identifier.urihttps://dspace.rsu.lv/jspui/handle/123456789/17060
dc.identifier.urlhttp://www.scopus.com/inward/record.url?scp=85214479571&partnerID=8YFLogxK
dc.language.isoeng
dc.relation.ispartofJournal of Clinical Medicine
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectcervical intraepithelial neoplasia
dc.subjectcervical precancerous disease
dc.subjectcolposcopy
dc.subjectglycyrrhizinic acid
dc.subjecthuman papillomavirus
dc.subject3.2 Clinical medicine
dc.subject1.1. Scientific article indexed in Web of Science and/or Scopus database
dc.subjectGeneral Medicine
dc.subjectSDG 3 - Good Health and Well-being
dc.titleEfficacy of Topical Treatment of Low-Risk Cervical Preinvasive Lesions with Glycyrrhizinic Aciden
dc.type/dk/atira/pure/researchoutput/researchoutputtypes/contributiontojournal/article

Files

Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
jcm-14-00136.pdf
Size:
2.19 MB
Format:
Adobe Portable Document Format
Download

Collections

Research outputs from Pure / Zinātniskās darbības rezultāti no ZDIS Pure